Growth Metrics

Rxo (RXO) Return on Equity (2022 - 2025)

Rxo (RXO) has disclosed Return on Equity for 4 consecutive years, with 0.06% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 11.0% year-over-year to 0.06%, compared with a TTM value of 0.06% through Dec 2025, up 11.0%, and an annual FY2025 reading of 0.06%, up 20.0% over the prior year.
  • Return on Equity was 0.06% for Q4 2025 at Rxo, down from 0.05% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.12% in Q3 2022 and bottomed at 0.24% in Q3 2024.
  • Average Return on Equity over 4 years is 0.04%, with a median of 0.03% recorded in 2024.
  • The sharpest move saw Return on Equity decreased -23bps in 2024, then rose 19bps in 2025.
  • Year by year, Return on Equity stood at 0.11% in 2022, then crashed by -94bps to 0.01% in 2023, then tumbled by -2730bps to 0.18% in 2024, then surged by 64bps to 0.06% in 2025.
  • Business Quant data shows Return on Equity for RXO at 0.06% in Q4 2025, 0.05% in Q3 2025, and 0.19% in Q2 2025.